Important Information

AMP 2014 Annual Meeting
November 13 -15, 2014
For More Information

Corporate Workshop Day & Gala, November 12, 2014

Gaylord National Resort & Convention Center
National Harbor, MD (just outside of Washington, DC)

Special Features

AMP International
AMP Test Directory
Awards, Grants & Honors
Career Development
Membership Information
Online Member Directory
The Journal of Molecular Diagnostics
Trainee Programs
Web Library

How to Help

Corporate Support Opportunities
Donate to AMP


AP RSS Feed Linked In FaceBook Twitter
more information

Advocacy Home Page

AMP Press Releases

AMP Position Statements and Letters





AMP Position statements and letters

AMP Position Statements and Letters - 2010


2010 Title Keywords Committee


Comments to the SACGHS re: Whole Genome Sequencing


Whole Genome Analysis Working Group


Letter to FDA Expressing Concerns Over Potential Medical Device Registration Requirement


Multi-Association Coalition



Letter to FDA Encouraging Continued Dialogue re: LDTs


Multi-Association Coalition



Comments to NIH regarding the Genetic Test Registry


Professional Relations


Comments to FDA regarding oversight of laboratory developed tests


Professional Relations






Comments to SACGHS regarding the draft report on Genetics Education and Training


Professional Relations


Comments to FDA regarding regulation of cytogenetic arrays


Arrays Working Group


Comments to FDA CDRH Council regarding barriers to market for molecular diagnostic tests


Professional Relations


Comments to SACGHS regarding Whole Genome Sequencing


Clinical Practice






Comments to the SACGHS to finalize gene patent report and recommendations as presented in October 2009


Professional Relations





  Comments to AHRQ on the draft Technology Assessment, "Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment"   Professional Relations


AMP's position on the oversight of laboratory developed tests (LDTs) released and discussed with FDA


Professional Relations


AMP presents to MEDCAC regarding pharmacogenomic testing


Professional Relations